Rearrangements of chromosome 3q26, which lead to upregulation of EVI1, frequently occur in myeloid malignant diseases including MDS, AML, and chronic myeloid leukemia (CML) (8–10). The gene discussed is MECOM; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.